F10 and stroke disorder: In patients with non-valvular atrial fibrillation (NVAF), direct oral anticoagulants (DOACs), such as factor Xa inhibitors and direct thrombin inhibitors, are recommended over vitamin K antagonists (VKAs) for stroke prevention [6].